Rui Avelar sold $147k of EOLS
See Remarks at Evolus, Inc.. 29,996 shares at an average of $4.89, traded Mar 17, 2026, filed Mar 18, 2026.
Score components
- +15RoleOfficer
- +11Trade size$147k at market
- 0Share of holdings soldSold 6.5% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -2.9%, 3m +39.5%, 6m +65.4%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001570562-26-000045, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | MOption exercise Common Stock10b5-1 | +8,804 | $0.00 | $0 | 460,538 | Mar 18, 2026 |
| Mar 17, 2026 | SOpen-market sale Common Stock10b5-1 | -29,996 | $4.89 | $147k | 430,542 | Mar 18, 2026 |
| Mar 16, 2026 | MOption exercise Performance Restricted Stock Unitsderivative10b5-1 | -8,804 | $0.00 | $0 | 8,802 | Mar 18, 2026 |
Related signals
Other insiders at Evolus, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 44Moderate | EOLSsell Evolus, Inc. | David Moatazedi See Remarks | $950k 105,108 shares | -17% | |
| 3Weak | Evolus, Inc. | Rui Avelar See Remarks | $15k 3,119 shares | -1% | |
| 11Weak | Evolus, Inc. | David Moatazedi See Remarks | $65k 13,669 shares | -2% | |
| 12Weak | Evolus, Inc. | David Moatazedi See Remarks | $571k 116,720 shares | -16% | |
| 3Weak | Evolus, Inc. | Rui Avelar See Remarks | $16k 2,261 shares | -1% | |
| 11Weak | Evolus, Inc. | David Moatazedi See Remarks | $75k 10,539 shares | -3% | |
| 1Weak | Evolus, Inc. | Tomoko Yamagishi-Dressler Chief Marketing Officer | $43k 5,722 shares | -6% | |
| 45Moderate | EOLSbuy Evolus, Inc. | Brady Stewart director | $204k 30,000 shares | +51% | |
| 50Moderate | EOLSsell Evolus, Inc. | David Moatazedi See Remarks | $1.3M 127,905 shares | -26% | |
| 55Moderate | EOLSbuy Evolus, Inc. | Albert G White III director | $189k 20,000 shares | +66% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.